Abstract
Background and aims: The non-steroidal anti-inflammatory drugs (NSAID) induced mucosal lesions are well-known and well-defined in the gastroduodenal tract. Much less in known about the NSAID provoked alterations in the small bowel, however a significant proportion of the patients take NSAIDs with a daily frequency. The aim of our prospective pilot capsule endoscopy (CE) study was to evaluate the small bowel mucosal pathology in patients with continuous NSAID intake.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
